Skip to main content
NY Home homeNews home
Story

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer - CNBC

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer  CNBC Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera  Reuters Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera  Barron's Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga  Bloomberg.com Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game  MarketWatch

Latest News